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Abstract
Background: Fetal and neonatal mortality rates in low-income countries are at least 10-fold greater than in high-income
countries. These differences have been related to poor access to and poor quality of obstetric and neonatal care.
Methods: This trial tested the hypothesis that teams of health care providers, administrators and local residents can
address the problem of limited access to quality obstetric and neonatal care and lead to a reduction in perinatal
mortality in intervention compared to control locations. In seven geographic areas in five low-income and one
middle-income country, most with high perinatal mortality rates and substantial numbers of home deliveries, we
performed a cluster randomized non-masked trial of a package of interventions that included community mobilization
focusing on birth planning and hospital transport, community birth attendant training in problem recognition, and
facility staff training in the management of obstetric and neonatal emergencies. The primary outcome was perinatal
mortality at ≥28 weeks gestation or birth weight ≥1000 g.
Results: Despite extensive effort in all sites in each of the three intervention areas, no differences emerged in the
primary or any secondary outcome between the intervention and control clusters. In both groups, the mean perinatal
mortality was 40.1/1,000 births (P = 0.9996). Neither were there differences between the two groups in outcomes in
the last six months of the project, in the year following intervention cessation, nor in the clusters that best
implemented the intervention.
Conclusions: This cluster randomized comprehensive, large-scale, multi-sector intervention did not result in detectable
impact on the proposed outcomes. While this does not negate the importance of these interventions, we expect that
achieving improvement in pregnancy outcomes in these settings will require substantially more obstetric and neonatal
care infrastructure than was available at the sites during this trial, and without them provider training and community
mobilization will not be sufficient. Our results highlight the critical importance of evaluating outcomes in randomized
trials, as interventions that should be effective may not be.
Trial registration: ClinicalTrials.gov NCT01073488
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Background
Complications during labor and delivery are responsible
for half the maternal deaths, one-third of stillbirths and a
quarter of neonatal deaths occurring each year worldwide
[1-8]. These complications, for example, prolonged labor,
preeclampsia, infection and hemorrhage, also cause a
substantial amount of maternal morbidity and stillbirths
and contribute to neonatal mortality and long-term
disability [1,2,6]. Antenatal assessment often fails to
predict which women will have complications and
when these will occur. Their effective management often
necessitates urgent, facility-based management of labor
by a skilled birth attendant with the ability to provide
parenteral medications, carry out procedures, including
blood transfusions and cesarean sections, and provide new-
born care/resuscitation [4]. However, health care systems
in many developing countries struggle to provide skilled
attendance and necessary emergency obstetric care [9,10].
Sixty million births per year world-wide currently occur
outside facilities, usually without skilled attendance [10].
When an obstetric emergency occurs, women delivering
in these settings are at high risk of poor outcomes due to
lack of appropriate services. Attempts to reduce perinatal
deaths generally focus on medical treatments, community-
participatory approaches or health system interventions
[5,11-13]. Programs have used various combinations of
these interventions [14-22]; however, simultaneous in-
tegration of these strategies has not been adequately
evaluated to determine whether in aggregate they would
reduce perinatal deaths.
A brief discussion of justification for including specific
components in our intervention package follows. 1)
Community participatory approaches have suggested
reductions in maternal/neonatal mortality in Bolivia,
India, Bangladesh and Nepal [18-22]. Changing behavior of
families and communities during pregnancy and reducing
barriers to health service by addressing context-specific
delays (for example, birth preparedness, availability of
funds, transport mechanisms) have the potential to improve
outcomes in populations where most deliveries occur at
home or in primary health facilities [23]. 2) Traditional
birth attendants (TBAs) remain a major provider of de-
livery care, especially in settings where mortality rates
are highest [24]. Despite the lack of evidence supporting
TBA training as a single intervention to reduce mortality
[25], some research supports the inclusion of TBAs within
an improved health care system focusing on early recogni-
tion of obstetric complications and appropriate referral to
obstetric care facilities [13-15]. The Global Network’s
FIRST BREATH Trial, in which all birth attendants, includ-
ing TBAs, were taught the World Health Organization’s
essential newborn care with emphasis on neonatal resusci-
tation, suggested a reduction of perinatal mortality associ-
ated with this training [26]. 3) Finally, facilities in settings
with the worst outcomes are often unable to appropriately
implement emergency obstetric and neonatal care pack-
ages. Efforts to improve quality of care have focused on
in-service training, obstetric simulations/drills or perinatal
death audits to improve quality and institute solutions for
problems that caused fatalities [27].
This trial tested the hypothesis that teams of health care
providers, administrators and local residents can address
the limited access to quality obstetric and neonatal care
leading to a reduction in perinatal mortality in intervention
compared to control locations. These teams worked
with their communities and the existing health system
to implement a broad package of interventions including
community mobilization to establish and sustain mecha-
nisms of transport and payment; training to recognize
obstetric emergencies and stabilization and appropriate
referral for women delivering at home or in first level
care facilities; and improvement of quality of care in
existing health facilities.
Methods
Study design and setting
This trial was undertaken by the Global Network for
Women’s and Children’s Health Research (GN) supported
by the Eunice Kennedy Shriver National Institute of Child
Health and Human Development [28]. The GN, a multi-
country research network with seven research sites in
six countries, conducts research to evaluate interven-
tions to reduce maternal and perinatal mortality and
morbidity. All seven GN sites participated in the trial,
including two in India (Belgaum and Nagpur), and sites
in Pakistan, Kenya, Zambia, Guatemala and Argentina.
Descriptions of the site populations and resources have
been published [28,29].
Details of the trial methods have been described [30].
Briefly, we conducted a community-based, two-arm clus-
ter-randomized trial, including all pregnancies of residents
in 106 clusters. A cluster is a distinct geographic area with
approximately 500 births per year. Intervention start dates
ranged from March to August 2009 and the project inter-
vention period was terminated for all sites on 30 September
2011. Data for the first six months of the implementation
were not included in the analysis data set. Thus, the
primary outcome period was 18 months (two sites) to
24 months (five sites). We also present outcome data
for the last six months of the intervention period and,
because a pregnancy registry is ongoing, the full year
following cessation of the intervention.
Subjects
Each site had a pre-existing, independent maternal-
newborn health registry system to screen, enroll, and
track all pregnant women in the study clusters [28]. Regis-
try administrators enrolled women during pregnancy,
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obtained informed consent for the trial, and recorded
all intervention and control cluster delivery outcomes,
including stillbirths and neonatal deaths, and all deaths
of pregnant women through 42 days post-delivery or
pregnancy termination. Outcomes for all women with
births ≥1000 grams and or ≥28 weeks residing within
the study cluster for at least four weeks prior to deliv-
ery and who consented were included in study. Study
site ethics/institutional review boards, partnering US
institutions, and RTI International approved the proto-
col. The trial was registered at ClinicalTrials.gov (NCT
ID# NCT01073488).
Based on previously collected data, the 106 study clusters
had a mean perinatal death <7 days of age of 40 to 50 per
1,000 deliveries and an intra-class correlation coefficient
between 0.005 and 0.01 [26]. Using a two-sided hypothesis
test at 5% significance, these 106 clusters, with a minimum
of 18 month outcome data, provided a power of at least
80% to detect a 25% reduction in perinatal mortality.
Randomization and masking
Randomization was performed at the cluster level, strati-
fying by rates of the primary outcome (stillbirth and
early neonatal death) and number of deliveries. The
data coordinating center (Research Triangle Institute)
produced a computer-generated randomization algorithm
which assigned clusters at a 1:1 ratio within each stratum.
Because of the nature of the intervention, there was no
masking.
Intervention
Under direction of the GN Steering Committee, a team of
GN investigators, trainers with expertise in community
mobilization, TBA training and facility quality improvement
designed the intervention and provided study oversight
(See Figure 1). At each international site, an intervention
team of senior health, health system and study personnel,
meeting at least monthly, oversaw the project implemen-
tation. Trainers with extensive experience in community
Figure 1 EmONC Study Organization.
Table 1 Training
Intervention Purpose Major areas of maternal/newborn
mortality addressed
Prior research
Community mobilization [18] To ensure community recognition
of pregnancy complications and
their importance and to mobilize
resources for maternal and newborn
care including transportation to an
appropriate facility
The community training focused on
the major complications that killed
women and newborns such as
bleeding, preeclampsia/eclampsia,
infections, asphyxia and prematurity
and the importance of receiving
appropriate care for these conditions.
Studies conducted in Nepal,
Bangladesh, Pakistan etc.
suggested program effectively
facilitates community
change [19-23]
ACNM home-based
life-savings skills [31]
To train community birth attendants Recognition of danger signs, stabilization
and referral of mother for obstetric
hemorrhage, preeclampsia/eclampsia,
sepsis; newborn resuscitation and
appropriate referral were emphasized
Studies conducted in Bangladesh,
Indonesia and Liberia suggest
that the curriculum effectively
provides essential skills to nurse
midwives and community birth
attendants [32-36]
Jhpeigo emergency obstetric
and newborn care curriculum [37]
To train facility-based health care
providers to manage obstetric
and neonatal complications and
to audit maternal, fetal and
neonatal deaths.
The modules addressed the major causes
of maternal, fetal and newborn mortality
(obstetric hemorrhage, preeclampsia/
eclampsia, infection, asphyxia, and
prematurity). Death audits, emergency
drills, and facility audits were part of
the training
EmONC training has been
evaluated [15] and the Jhpeigo
curriculum tested [38]; evidence
for audits to improve care
demonstrated [39]
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mobilization, others with experience in training commu-
nity birth attendants and physicians with expertise in facil-
ity staff training were part of the country intervention
team and participated in training in the individual clusters.
In each study cluster, a cluster team comprising health
care providers, local residents and study personnel was
formed to develop and implement comprehensive inter-
ventions to improve the quality of obstetric and neonatal
care. These cluster teams worked within their community
and the local health care system to introduce these inter-
ventions. Maternal and perinatal mortality audits, facility-
level provider training and facility reviews were conducted
as quality improvement activities at the facility level. In
addition, at the community level, village-level core groups
were formed which facilitated community meetings of
mothers, family and community birth attendants over
the course of the trial. In summary, the cluster teams
facilitated a multi-faceted intervention which included
the following:
 Community mobilization to establish village-level
core groups and to strengthen community capacity
to identify and address barriers to obstetric and
neonatal care such as recognition of complications
and transportation to a facility to manage the
complication [18]. Each village-level core group was
trained to move through a cycle to organize, plan,
explore, act, and to evaluate maternal and perinatal
outcomes within their community.
 Home-based Life Savings Skills (HBLSS) training
was provided for birth attendants and families to
recognize prolonged labor, infection, preeclampsia
and hemorrhage, and the use of appropriate
stabilization methods that can be employed in
homes and in first level care facilities [31-36]; and,
improvement of quality of care in existing health
facilities through a combination of facility staff
Emergency Obstetric and Newborn Care (EMONC)
training for clinical care of the major causes of
Randomized
Clusters: N=106
Control
Clusters: N=53
EmONC Intervention
Clusters: N=53
Six Week Follow-up
Women with follow-up visit: N=55,712
Died prior to follow -up: N=76
Alive at follow-up: N=55,636
Infants with follow-up visit: N=56,223
Died prior to follow-up: N=3,127
Alive at follow-up: N=53,096
Delivery
Pregnant women delivered: N=56,091
Infants ≥ 1000g: N=56,591
Stillbirths ≥ 1000g: N=1,422
Live births ≥ 1000g: N=55,169
Enrollment
Women Screened: N=70,351
Eligible for Registry: N=68,499
Consented: N=68,351
Cluster Residents: N=59,189
Enrollment
Women Screened: N=66,830
Eligible for Registry: N=66,393
Consented: N=66,317
Cluster Residents: N=57,929
Delivery
Pregnant women delivered: N=55,104
Infants ≥1000g: N=55,586
Stillbirths ≥ 1000g: N=1,485
Live births ≥ 1000g: N=54,101
Exclusions (N=3,139)
Missing at delivery: N=535
Ineligible: N=2,604
Exclusions (N=2,862)
Missing at delivery: N=419
Ineligible: N=2,433
Exclusions
Missing: N=747
Six Week Follow-up
Women with follow-up visit: N=54,822
Died prior to follow -up: N=77
Alive at follow-up: N=54,745
Infants with follow-up visit: N=55,306
Died prior to follow-up: N=3,037
Alive at follow-up: N=52,269
Exclusions
Missing: N=562
Figure 2 Consort diagram.
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maternal and newborn mortality [37], perinatal and
maternal death audits [38,39] and health facility
audits [29].
The EmONC trial used a train-the-trainer model for the
three main components (HBLSS, community mobilization
and facility EMONC training) and the modules which
were focused on the major causes of maternal, fetal and
neonatal mortality (Table 1). Experienced trainers for each
of the three components were identified and these ‘master
trainers’ with input from other experts, selected and
modified the existing curriculum and led the train-the-
trainer training as described below:
For HBLSS and community mobilization, the training
was combined and consisted of two in-country train-the-
trainer sessions (an initial two-week period with approxi-
mately 70 hours of course work and practicum utilizing
the home-based life-saving skills curriculum. The com-
munity mobilization/HBLSS training emphasized the
Community Action Cycle and the relevant HBLSS modules
to identify and perform life-saving measures for the
conditions associated with maternal and early newborn
mortality (for example, post-partum hemorrhage, pre-
eclampsia/eclampsia, low birth weight newborn care).
A second one-week in-country training of trainers and
cluster coordinators was held after 12 months. The in-
country trainers then trained all of the community birth
attendants in the curriculum; these training sessions
included an initial three-day training followed by ongoing
(minimal of monthly) training and community meetings.
Additionally, the in-country EMONC trainer, usually
an experienced obstetric physician, received a three-day
course using a train-the-trainer model at a central loca-
tion utilizing a modified version of the Jhpeigo EMONC
curriculum (37). This three-day training emphasized
the curriculum addressing post-partum hemorrhage,
preeclampsia/eclampsia and emergency preparedness.
The in-country trainers then carried out training for
the hospitals serving their intervention clusters with the
amount of training, including an initial three to five day
session to cover the essential elements with additional
time dedicated to follow-up training, varying based on
local assessment of facility needs. For each of these
components, the master trainers participated in central
training, followed by in-country training every six
months during the 24-month trial period. Each of the
training sessions included pre and post-tests to assess
knowledge and skills acquisition.
In anticipation that the package of interventions would
be better introduced in some clusters than others, we a
priori created a system for measuring the integrity of the
intervention, with credit given for reaching the targets for
four intervention measures including monthly cluster team
meetings, death audits, village-level core group activities
and village-level core groups reaching the ‘act’ phase of
the community action cycle.
Study outcomes
The primary outcome was perinatal mortality, defined as
the composite of stillbirth and seven-day neonatal mortality
per 1,000 births among births occurring at ≥28 weeks
gestation or birth weight ≥1000 g. Secondary outcomes
included rates of stillbirth (both fresh and macerated),
Table 2 Maternal and neonatal characteristics
Group
Treatment Control
Total clusters, N 53 53
Deliveries by country, N
Argentina (6 clusters) 2,483 2,717
Guatemala (10 clusters) 6,898 5,405
Kenya (16 clusters) 5,962 7,401
Zambia (10 clusters) 6,455 7,423
Belgaum, India (20 clusters) 14,317 12,585
Nagpur, India (20 clusters) 6,535 5,966
Pakistan (24 clusters) 13,080 13,338
Mothers (N) 55,730 54,835
Maternal education, N (%) 55,325 54,524
No formal schooling 16,781 (30.3) 16,245 (29.8)
Primary 22,016 (39.8) 20,485 (37.6)
Secondary 13,476 (24.4) 14,879 (27.3)
University + 3,052 (5.5) 2,915 (5.3)
Maternal age, N (%) 55,602 54,757
< 20 6,870 (12.4) 6,838 (12.5)
20 to 35 46,320 (83.3) 45,339 (82.8)
> 35 2,412 (4.3) 2,580 (4.7)
Parity, N (%) 55,619 54,754
0 16,986 (30.5) 16,663 (30.4)
1 to 4 31,687 (57.0) 30,949 (56.5)
> 4 6,946 (12.5) 7,142 (13.0)
Infants ≥1000 g, N 56,223 55,306
Birth weight, N (%) 56,223 55,306
1000 to 1499 g 687 (1.2) 739 (1.3)
1500 to 2499 g 6,170 (11.0) 5,431 (9.8)
≥2500 g 49,366 (87.8) 49,136 (88.8)
Gestational age, N (%) 56,128 55,197
Term 51,681 (92.1) 51,409 (93.1)
Preterm 4,447 (7.9) 3,788 (6.9)
Gender, N (%) 56,174 55,233
Male 28,989 (51.6) 28,964 (52.4)
Female 27,185 (48.4) 26,269 (47.6)
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seven-day neonatal mortality, 28-day neonatal mortality
and maternal death. Process measures, such as rates of
transport to hospital of mothers and newborns and
facility delivery, were also determined. Each of these
measures was assessed in both intervention and control
clusters through the registries, with registry teams distinct
from those implementing the interventions. We also col-
lected extensive data on the intervention itself including
number and type of cluster and community meetings,
death audits and providers trained.
Statistical analyses
Data were entered at each study site with inter- and
intra-data edits and consistency checks performed. The
Data Monitoring Committee reviewed the data for safety
and efficacy. Generalized estimating equations (GEE)
extensions of a log-binomial for multivariate logistic
regression model that accounted for the study design
strata and correlation between outcomes in the same
cluster tested for differences in the primary outcome.
Secondary outcome analyses were conducted using GEE
extensions of either log-binomial or robust Poisson re-
gression models for binary outcomes and clustered
multinomial logistic regression model extensions for
ordinal outcomes. All analyses were performed using SAS
version 9.3 (SAS Institute, Cary, NC), with the exception
of the multinomial logistic regression models, which were
performed using SUDAAN 11.
Ethics approval and consent
The Ethics Review Committees of each participating insti-
tution and the data coordinating center (RTI International)
all approved the study protocol. Informed consent was
obtained from all women who participated in the study.
Role of funding source
This trial was funded by grants from the US National
Institutes of Health (NIH). The NIH program officers
(LLW, MKT) participated in the protocol development
and study monitoring, and reviewed the manuscript.
Results
A total of 106 clusters, ranging from 6 in Argentina to 24
in Pakistan, were randomized, with 53 in each treatment
group (Figure 2). A total of 70,351 pregnant women were
screened in the intervention clusters and 66,830 in the
Table 3 The number of activities in intervention clusters by study site and where appropriate, means and percentages
Total Argentina Guatemala Kenya Zambia Belgaum, India Nagpur, India Pakistan
Cluster team-led activities
Total activities, N 50,433 322 1,916 5,703 7,941 3,272 13,053 18,226
Facility training 1,309 94 115 183 27 497 80 313
HBLSS training 26,623 101 559 2,898 4054 698 7,569 10,744
Community training or meeting 21,060 111 1,095 2,595 3814 2,059 5,404 6,054
Other activity 1,441 16 147 99 46 18 0 1,115
Health facility provider training
Providers trained, N 1,459 76 364 140 302 295 209 73
Health facility reviews
Total facilities, N 304 3 23 22 9 69 130 48
Average reviews per facility, 4.1 (1.0) 5.0 (0.0) 4.8 (0.4) 3.5 (0.7) 5.0 (0.0) 4.6 (0.7) 3.5 (0.8) 4.3 (1.3)
Mean (SD)
Facility death audits, 5,039 (126.3) 86 (103.6) 382 (117.9) 180 (84.1) 309 (110.0) 1,287 (104.6) 321 (92.5) 2,474 (163.6)
N (% of total deaths)
Core groups
Core groups, N 3,721 7 50 231 160 667 1,028 1,578
Total meetings, N 119,200 187 1,681 9,960 8,861 33,802 11,949 52,760
Community mobilization stage
reached by core groups, N (%)
Organize 3,396 (91.3) 3 (42.9) 50 (100.0) 216 (93.5) 159 (99.4) 665 (99.7) 932 (90.7) 1,371 (86.9)
Explore 3,536 (95.0) 5 (71.4) 49 (98.0) 231 (100.0) 159 (99.4) 666 (99.9) 886 (86.2) 1,540 (97.6)
Plan 3,486 (93.7) 6 (85.7) 44 (88.0) 231 (100.0) 160 (100.0) 661 (99.1) 828 (80.5) 1,556 (98.6)
Act 3,600 (96.7) 6 (85.7) 49 (98.0) 220 (95.2) 160 (100.0) 661 (99.1) 1,006 (97.9) 1,498 (94.9)
Evaluate 2,647 (71.1) 3 (42.9) 46 (92.0) 160 (69.3) 54 (33.8) 660 (99.0) 441 (42.9) 1,283 (81.3)
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control clusters; of these, 59,189 (84%) and 57,929 (87%)
women were eligible and consented in the intervention
and control groups, respectively. Those women excluded,
for the most part, did not reside in the cluster for a full
four weeks prior to delivery. An additional 3,139 (4.5%)
and 2,862 (4.3%) deliveries in intervention and control
clusters were excluded at delivery due to missing data
or other ineligibility criteria. Outcomes were obtained
for >99% of eligible women at six-weeks post-delivery
(55,712 and 54,822 in the intervention and control clusters,
respectively).
Demographic characteristics of the intervention and
control participants are shown in Table 2. Overall, almost
one-third of women had no formal schooling and 5%
had university-level education. Approximately 12% of
the mothers were <20 years of age and 83% were 20 to
35 years old. In both groups, about 30% of the women
were primiparous; over 12% had more than four prior
pregnancies. Table 2 also shows the birthweight, gesta-
tional age, and gender distributions. Although there
were small differences, none were statistically significant
at P <0.05.
Table 3 shows the number of interventions applied in
the treatment clusters by site, emphasizing the great
amount of work done by the site and cluster teams. The
53 intervention cluster teams (one per cluster) led more
than 50,000 cluster-level activities, including meetings,
trainings and other community sensitization activities. The
specific activities included facility training (n = 1,309),
HBLSS training (n = 26,623), community mobilization
training (n = 21,060) and other meetings (n = 1,441). There
were a total of 304 facility reviews; on average, each facility
was reviewed more than four times during the trial. There
were 5,039 facility death audits. In each site, more death au-
dits were completed than there were study deaths because
facility audits included deaths of women and their new-
borns from non-study areas. Village-level core groups
went through the community action cycle stages (organize,
explore, plan, act and evaluate) generally in sequential
order; however, due to occasional division of one into two
core groups, a few appear to start the sequence at mid-
cycle. The primary issues identified during these activities
were difficulty recognizing that the mother/baby had a
problem requiring treatment, lack of transportation and
lack of funds to pay for facility care (data not shown).
Altogether, 96.7% of the village-level core groups reached
the act stage by the end of the trial. Using these data and
the a priori criteria for implementing the intervention,
37.7% of the clusters met two or fewer criteria, 32.1% of the
clusters met three criteria, and 30.2% met all four criteria.
Table 4 summarizes the indicators of the antenatal and
delivery care by intervention and control groups after
Table 4 Indicators of quality of care by treatment group
Group
Intervention Control P-value
Clusters, N 53 53
Mothers with infants ≥1000 g, N 55,730 54,835
Indicators of quality care, Mean (95% CI)
Attended at least one antenatal care class 59.7 (55.8, 63.7) 59.7 (55.8, 63.5) 0.6687
Access to an emergency fund/plan for hospital delivery 61.3 (54.3, 68.3) 56.8 (50.2, 63.4) 0.3541
Birth attendant identified prior to birth 87.1 (82.6, 91.7) 84.6 (79.5, 89.7) 0.3269
Identified birth attendant present at birth 71.0 (66.8, 75.2) 71.8 (66.5, 77.2) 0.8045
Transport identified prior to birth 62.0 (55.5, 68.6) 62.3 (56.4, 68.1) 0.9570
Received tetanus toxoid vaccine 87.9 (86.3, 89.4) 87.9 (86.4, 89.5) 0.2808
Received prenatal vitamins/iron 89.6 (87.9, 91.4) 89.8 (88.1, 91.4) 0.1792
Received syphilis test 18.5 (14.9, 23.0) 19.5 (15.4, 24.8) 0.5237
Received HIV test 71.2 (69.2, 73.2) 71.3 (69.1, 73.4) 0.9457
Cesarean section (of all deliveries) 11.7 (10.1, 13.2) 11.9 (10.4, 13.4) 0.5022
Physician or nurse/midwife deliveries 65.0 (62.5, 67.6) 64.8 (61.9, 67.6) 0.7053
Traditional birth attendant deliveries 32.4 (26.3, 38.4) 32.5 (26.2, 38.9) 0.8998
Hospital deliveries 38.6 (32.4, 44.7) 40.3 (33.6, 47.0) 0.4801
Clinic/health center deliveries 24.6 (20.4, 28.8) 24.0 (19.3, 28.7) 0.9131
Clean razor was used to cut cord 87.6 (86.0, 89.3) 87.5 (85.9, 89.2) 0.4844
Birth attendant used new gloves 95.5 (94.3, 96.6) 95.7 (94.8, 96.6) 0.5934
Newborn resuscitated with bag and mask 2.6 (1.9, 3.3) 3.1 (2.1, 4.1) 0.3769
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the trial’s initiation. In both arms, almost 60% of women
attended at least one antenatal class. More than three-
fifths of women in both groups reported having access
to emergency transport, if necessary, for delivery, and
the rate of facility delivery in both groups was 65%. In
the intervention group, 61.3% of women reported access
to emergency funds in case a facility delivery was needed,
compared to 56.8% in the control group and 87.1% of
women in the intervention group had identified a birth
attendant prior to delivery compared to 84.6% in the
control group. However, neither of these differences
rose to statistical significance.
Table 5 first shows the primary outcome of perinatal
mortality and the secondary outcomes for the 18 to 24
months of the intervention. In both the intervention and
the control clusters, the mean perinatal mortality was
40.1/1,000 births (P = 0.9996). None of the secondary
outcomes differed significantly between groups. Next, to
determine whether differences developed only late in the
project, we evaluated each outcome in the last six months
of the intervention. No significant differences in outcome
emerged. Finally, we examined the primary outcomes for
intervention compared to control clusters in the 12
months post-trial and found no significant differences in
any outcome measure. We also compared the outcomes
in the better performing intervention clusters to their
controls for the entire intervention time period, and for
the last six months of the intervention (Table 6). There
Table 5 Neonatal and maternal mortality outcomes by treatment for all clusters
Group
Intervention Control P-value
Clusters, N 53 53
Outcomes for full intervention period
Births ≥1000 g, N 56,223 55,306
Outcomes - Mean (95% CI)
Perinatal mortality (<7 days) (Rate/1,000) 40.1 (37.3, 42.9) 40.1 (37.4, 42.8) 0.9996
Stillbirths (Rate/1,000) 21.8 (19.8, 23.9) 22.6 (20.5, 24.6) 0.6177
Fresh stillbirth (Rate/1,000) 15.2 (13.4, 17.0) 15.5 (14.0, 17.0) 0.8082
Early neonatal mortality (<7 days) (Rate/1,000) 18.7 (17.3, 20.1) 18.2 (16.6, 19.7) 0.5950
Neonatal mortality (<28 days) (Rate/1,000) 23.8 (22.0, 25.5) 22.5 (20.6, 24.5) 0.3362
Fresh stillbirths + neonatal deaths <7 days (Rate/1,000) 33.8 (31.2, 36.3) 33.4 (31.2, 35.5) 0.8105
Maternal mortality (<42 days) (Rate/100,000) 125.1 (97.7, 160.2) 130.9 (104.5, 163.9) 0.7321
Outcomes for final six months of intervention period
Births ≥1,000 g, N 15,412 15,180
Outcomes - Mean (95% CI)
Perinatal mortality (<7 days) (Rate/1,000) 39.6 (35.8, 43.4) 41.4 (37.4, 45.5) 0.5043
Stillbirths (Rate/1,000) 21.6 (18.8, 24.4) 22.9 (19.7, 26.2) 0.5491
Fresh stillbirth (Rate/1,000) 15.2 (12.7, 17.7) 14.5 (12.2, 16.8) 0.6826
Early neonatal mortality (<7 days) (Rate/1,000) 18.7 (16.7, 20.8) 19.0 (16.8, 21.3) 0.8458
Neonatal mortality (<28 days) (Rate/1,000) 23.4 (21.0, 25.8) 22.9 (20.3, 25.6) 0.7822
Fresh stillbirths + neonatal deaths <7 days (Rate/1,000) 33.4 (30.1, 36.8) 33.4 (30.3, 36.4) 0.9734
Maternal mortality (<42 days) (Rate/100,000) 109.1 (64.5, 184.5) 78.3 (44.0, 139.3) 0.2799
Outcomes for 12-months post-intervention period
Births ≥1,000 g, N 27,852 26,356
Outcomes - Mean (95% CI)
Perinatal mortality (<7 days) (Rate/1,000) 37.9 (34.0, 41.7) 36.6 (33.2, 40.0) 0.6202
Stillbirths (Rate/1,000) 21.7 (19.2, 24.2) 21.1 (18.9, 23.4) 0.7406
Fresh stillbirth (Rate/1,000) 14.8 (12.7, 16.9) 14.1 (12.2, 16.0) 0.6271
Early neonatal mortality (<7 days) (Rate/1,000) 16.4 (14.5, 18.4) 15.9 (13.8, 18.0) 0.7136
Neonatal mortality (<28 days) (Rate/1,000) 21.4 (19.0, 23.8) 20.0 (17.5, 22.5) 0.4311
Fresh stillbirths + neonatal deaths <7 days (Rate/1,000) 31.3 (27.7, 34.9) 29.7 (26.6, 32.9) 0.5126
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were no significant differences in outcomes in either
time period.
Discussion
In geographic areas with high maternal and perinatal
mortality in seven sites in six countries, we found that a
multipronged intervention that included: 1) community
mobilization and birth attendant education focusing on
birth planning and transportation to a hospital; 2) birth
attendant recognition of complications, stabilization and
appropriate, timely referral to a hospital; and 3) hospital
staff training focusing on appropriate and timely manage-
ment of medical complications did not reduce perinatal
mortality.
We have considered the potential reasons why our
efforts did not achieve the hypothesized outcomes.
One possibility is that we had the right group of interven-
tions to achieve an important improvement in outcomes,
but that the intervention was not carried out sufficiently
well in enough clusters to impact either the process
measures or the outcomes. However, based on our ongoing
monitoring systems, we documented that the intervention
components were generally implemented with high fidelity.
The very large number of activities documented plus the
fact that there was no improvement in outcomes even
among the best performing clusters, suggests this was not
the case. Another possibility is that our chosen package of
interventions was not implementable with the resources
or time allowed for this project. However, substantial
resources were allocated to the intervention (each study
site had a budget over the two years of approximately
$500,000 USD or on average about $60,000 USD per
intervention cluster) and many of the clusters achieved
substantial compliance in most components of the inter-
vention. That there were no observable improvements in
outcome in the final six months of the intervention or
even in the year after the intervention ceased, suggests
that insufficient time was not responsible for the lack of
observed improvement in outcome. Another possibility is
that although we had three intervention components,
most sites appeared to give more attention to community
mobilization and community birth attendant training and
less to hospital staff training. Since a well-functioning
hospital and a trained, motivated staff seem crucial for
Table 6 Neonatal and maternal outcomes for well performing intervention clusters and control clusters in the same
strata for the entire intervention and restricted to the last six months of the intervention
Group
Well performing
intervention clusters
Control
clusters same strata
P-value
Clusters, N 33 36
Outcomes for full intervention period
Births ≥1,000 g, N 40,897 42,662
Primary outcome - Mean (95% CI)
Perinatal mortality (<7 days) (Rate/1,000) 40.6 (37.0, 44.1) 40.4 (37.0, 43.7) 0.9404
Secondary outcomes - Mean (95% CI)
Stillbirths (Rate/1,000) 21.8 (19.2, 24.5) 23.3 (21.0, 25.6) 0.4087
Fresh stillbirth (Rate/1,000) 14.9 (12.5, 17.3) 15.7 (14.0, 17.4) 0.5504
Early neonatal mortality (<7 days) (Rate/1,000) 19.2 (17.6, 20.8) 17.8 (16.2, 19.3) 0.2095
Neonatal mortality (<28 days) (Rate/1,000) 24.6 (22.6, 26.7) 21.9 (20.0, 23.7) 0.0516
Fresh stillbirths + neonatal deaths <7 days (Rate/1,000) 33.9 (30.6, 37.1) 33.2 (30.4, 36.0) 0.7365
Maternal mortality (<42 days) (Rate/100,000) 103.2 (71.7, 148.5) 108.5 (76.0, 154.8) 0.7425
Outcomes for final six months of intervention period
Births ≥1,000 g, N 10,514 10,568
Primary outcome - Mean (95% CI)
Perinatal mortality (<7 days) (Rate/1,000) 38.1 (33.6, 42.6) 41.3 (36.5, 46.1) 0.3666
Secondary outcomes - Mean (95% CI)
Stillbirths (Rate/1,000) 21.3 (18.0, 24.6) 23.2 (19.4, 27.0) 0.4976
Fresh stillbirth (Rate / 1,000) 14.4 (11.3, 17.5) 13.3 (10.9, 15.8) 0.6080
Early neonatal mortality (<7 days) (Rate/1,000) 17.7 (14.8, 20.6) 18.7 (15.7, 21.7) 0.6118
Neonatal mortality (<28 days) (Rate/1,000) 23.0 (19.3, 26.8) 22.8 (19.1, 26.5) 0.9220
Fresh stillbirths + neonatal deaths <7 days (Rate/1,000) 31.4 (27.3, 35.6) 32.1 (28.7, 35.5) 0.8153
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achieving the level of mortality reduction hoped for in this
study, it may be that hospital training was insufficient.
However, a substantial amount of hospital training oc-
curred, and potential areas for improvement were made
apparent to the hospital administrators and staff by the
facility and mortality audits.
A more likely explanation for the lack of improvement
in outcomes in the intervention clusters is that the
deficiencies in the health systems were beyond potential
improvement by our package of interventions. Without
appropriate complementary efforts by the ministries of
health or other agencies to strengthen the health care
infrastructure at referral facilities to ensure availability of
skilled personnel and access to comprehensive emergency
obstetric care including appropriate essential medications,
supplies, and equipment, it is likely that interventions
predominantly focusing on community mobilization and
birth attendant training alone are insufficient to achieve
the hoped-for results [22-25,29]. Community mobilization
or birth attendant training might only help to reduce
mortality beyond a certain level if there is a concurrent
improvement in the capacity for managing obstetric
and neonatal emergencies. Our study suggests that the
weaknesses of the delivering facilities and health systems
in the participating sites, including the lack of essential
medications, supplies and equipment, were not adequately
addressed by the three-pronged strategy used in this
trial [29].
This study had a number of strengths including the
participation of seven sites in six countries and the large
number of clusters. The populations in the intervention
and the control arms were similar. A further strength is
that the study was performed in locations which had
ongoing pregnancy registries with excellent follow-up of
mothers and infants, and with registry personnel distinct
from trial staff, reducing potential for bias. That data
collection continued for a full year after the intervention
ceased is a further strength. A potential weakness was that
all the clusters did not achieve complete implementation,
although a substantial amount of work was done in every
cluster. Another potential weakness was that because the
intervention could not be blinded, some of the control
clusters may have adopted a portion of the trial interven-
tions. We do not think that contamination occurred
frequently, but cannot rule out this possibility.
Conclusions
Our results are of major public health importance. First,
rolling out programs similar to the one tested here
without formal testing of their effectiveness will not
help to improve pregnancy-related outcomes nor achieve
progress toward Millennium Development Goals 4 and 5
to reduce maternal and child mortality. Second, we believe
that substantial attention to creating a system of maternal
and neonatal care with adequate supplies and infra-
structure, in addition to training of existing personnel, is
needed to achieve substantial improvements in pregnancy
outcomes - specifically systems that include appropriate
access to delivery facilities for all women, facilities with
sufficient equipment and access to essential medications,
and especially a well-trained and motivated staff with a
high degree of skill in treating obstetric and neonatal
emergencies. Our results suggest that in many low-
resource settings, it may take substantial resources and
time to create a sustainable and functioning maternal
and newborn care system to accomplish this goal than
were available for the current project.
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